TALVEY

This brand name is authorized in Austria, Cyprus, Estonia, Finland, France, Croatia, Ireland, Italy, Lithuania, Romania, United Kingdom, United States

Active ingredients

The drug TALVEY contains one active pharmaceutical ingredient (API):

1 Talquetamab UNII 4W3KFI3TN3 - TALQUETAMAB

Talquetamab is a immunoglobulin G4 proline, alanine, alanine (IgG4 PAA) bispecific antibody directed against GPRC5D and the CD3 receptor on T Cells. Talquetamab promotes enhanced T cell-mediated cytotoxicity through recruitment of CD3-expressing T cells to GPRC5D-expressing cells. Based on the expression of GPRC5D on plasma cells with minimal to no expression detected on B cells and B cell precursors, talquetamab targets multiple myeloma cells particularly. Read about Talquetamab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TALVEY Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FX29		L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FX Other monoclonal antibodies
Discover more medicines within L01FX29

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 3044999, 3045002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 194469, 453194
Country: FR	Base de données publique des médicaments	Identifier(s): 66105564, 66226822
Country: IT	Agenzia del Farmaco	Identifier(s): 050827017, 050827029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1097699, 1097700
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69749001, W69750001
Country: US	FDA, National Drug Code	Identifier(s): 57894-469, 57894-470